Nextbiotics Inc

Nextbiotics is a biotechnology and synthetic biology company headquartered in San Francisco, California that was founded in 2017 with the goal of leveraging cutting edge synthetic biology tools and bacteriophage technology to provide unique solutions to the antibiotic resistance crisis. The company combines bacteriophage therapy (Phage therapy) with CRISPR technology to reverse antibiotic resistance. The engineered viruses will specifically target drug-resistant bacteria and generate double-strand breaks, destroying the drug resistant genes or the genomic DNA of the bacteria, which will kill the bacteria.